Impact of psychological profile on healing of diabetic foot wounds
Official title: Evaluation of the Impact of Psychological Profile on Diabetic Foot Wound Healing. Prospective, Monocentric Study
Run by Centre Hospitalier Universitaire Dijon · NCT06630182 · Data updated 2026-11-12
This study looks at how different personality types in people with Type 2 diabetes affect the healing of their foot wounds.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 18 Years |
| Sex | All |
| Enrollment | 308 (estimated) |
| Sponsor | Centre Hospitalier Universitaire Dijon Academic / other |
| Locations | 1 site (Dijon) |
| Status | Recruiting |
| Started | September 11, 2024 |
| Main results expected | September 2028 |
| Study ends | September 2028 |
| Registry record updated | July 24, 2026 |
| Trial ID | NCT06630182 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old with Type 2 diabetes who have a new diabetic foot wound.
✕Probably not a fit
Patients who are unable to complete self-questionnaires or those under legal protection measures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates how different psychological profiles, specifically Type A and Type B, affect the healing process of foot wounds in patients with Type 2 diabetes. Participants will complete self-questionnaires based on Bortner's method to determine their psychological profile. The study aims to identify correlations between these profiles and wound healing outcomes, potentially informing future treatment approaches. It focuses on patients referred for management of new diabetic foot wounds.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for diabetic foot wounds by considering psychological factors.
How similar studies have gone: While there is some evidence linking psychological profiles to health outcomes in diabetes, this specific approach appears to be novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Person who has given his non-opposition * Person over 18 years of age * Person with type 2 diabetes * Person referred for management of a new diabetic foot wound Exclusion Criteria: * Person subject to a legal protection measure (curatorship, guardianship) * Person subject to a legal protection measure * Pregnant women, women in labour or breastfeeding mothers * An adult who is incapable or unable to give consent * Minors * Person unable to complete self-questionnaires
Where it's running
-
CHU Dijon Bourgogne
Dijon, France Recruiting
Study contacts
- Study coordinator: Benjamin BOUILLET
- Email: benjamin.bouillet@chu-dijon.fr
- Phone: 0380293453
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Acute Blood Flow Restriction Walking in Type 2 Diabetes
This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.
-
Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin
This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.
-
Differentiating heart disease in autoimmune vs. type 2 diabetes
This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes
This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.